Prudential Financial Inc Shattuck Labs, Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$1.37 - $7.24 $7,672 - $40,544
-5,600 Reduced 31.46%
12,200 $86,000
Q3 2023

Nov 13, 2023
BUY
$1.42 - $3.16 $4,828 - $10,744
3,400 Added 23.61%
17,800 $27,000
Q2 2023

Aug 11, 2023
BUY
$2.52 - $3.66 $36,288 - $52,704
14,400 New
14,400 $44,000
Q4 2022

Feb 14, 2023
BUY
$1.96 - $3.26 $31,850 - $52,975
16,250 New
16,250 $0

Others Institutions Holding STTK

# of Institutions
80
Shares Held
28.8M
Call Options Held
300
Put Options Held
1.2K
View Full List

About Shattuck Labs, Inc.

STTK Quotes by TradingView
  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $55.1M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email